Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by Analyst

StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report released on Thursday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of a number of other reports. HC Wainwright reissued a neutral rating and set a $2.15 price objective on […]

Related Keywords

Randallb Brenner , Williamm Haskel , , Paratek Pharmaceuticals Trading , Hunting Hill Global Capital , Paratek Pharmaceuticals Inc , Paratek Pharmaceuticals , Securities Exchange Commission , Institutional Trading Of Paratek Pharmaceuticals , News Ratings For Paratek Pharmaceuticals Daily , Carlyle Group Inc , Millennium Management , Polar Asset Management Partners Inc , Jefferies Financial Group , Free Report , Financial Group , Exchange Commission , General Counsel William , Asset Management Partners , Hill Global Capital , Get Free Report , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Prtk , Medical , 89354m10 , Initiated Coverage , Stocknews Com ,